These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Alteration of cardiac cytochrome P450-mediated arachidonic acid metabolism in response to lipopolysaccharide-induced acute systemic inflammation. Anwar-mohamed A; Zordoky BN; Aboutabl ME; El-Kadi AO Pharmacol Res; 2010 May; 61(5):410-8. PubMed ID: 20045729 [TBL] [Abstract][Full Text] [Related]
6. Acute arsenic treatment alters arachidonic acid and its associated metabolite levels in the brain of C57Bl/6 mice. Anwar-Mohamed A; Elshenawy OH; El-Sherbeni AA; Abdelrady M; El-Kadi AO Can J Physiol Pharmacol; 2014 Aug; 92(8):693-702. PubMed ID: 25065748 [TBL] [Abstract][Full Text] [Related]
7. Acute doxorubicin toxicity differentially alters cytochrome P450 expression and arachidonic acid metabolism in rat kidney and liver. Zordoky BN; Anwar-Mohamed A; Aboutabl ME; El-Kadi AO Drug Metab Dispos; 2011 Aug; 39(8):1440-50. PubMed ID: 21571947 [TBL] [Abstract][Full Text] [Related]
8. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases. Zordoky BN; El-Kadi AO Pharmacol Ther; 2010 Mar; 125(3):446-63. PubMed ID: 20093140 [TBL] [Abstract][Full Text] [Related]
9. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA. Diani-Moore S; Ma Y; Gross SS; Rifkind AB Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719 [TBL] [Abstract][Full Text] [Related]
11. Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats. Zordoky BN; Aboutabl ME; El-Kadi AO Drug Metab Dispos; 2008 Nov; 36(11):2277-86. PubMed ID: 18725507 [TBL] [Abstract][Full Text] [Related]
12. Effect of alcohol on cytochrome p450 arachidonic acid metabolism and blood pressure in rats and its modulation by red wine polyphenolics. Cowpland C; Su GM; Murray M; Puddey IB; Croft KD Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):183-8. PubMed ID: 16487260 [TBL] [Abstract][Full Text] [Related]
14. Bioactivation of arachidonic acid by the cytochrome P450 monooxygenases of guinea pig lung: the orthologue of cytochrome P450 2B4 is solely responsible for formation of epoxyeicosatrienoic acids. Knickle LC; Bend JR Mol Pharmacol; 1994 Jun; 45(6):1273-80. PubMed ID: 8022420 [TBL] [Abstract][Full Text] [Related]
15. Alteration of epoxyeicosatrienoic acids in the liver and kidney of cytochrome P450 4F2 transgenic mice. Zhang B; Lai G; Liu X; Zhao Y Mol Med Rep; 2016 Dec; 14(6):5739-5745. PubMed ID: 27878278 [TBL] [Abstract][Full Text] [Related]
16. Mechanism-based inactivation of cytochrome P450 1A1 by N-aralkyl-1-aminobenzotriazoles in guinea pig kidney in vivo and in vitro: minimal effects on metabolism of arachidonic acid by renal P450-dependent monooxygenases. Knickle LC; Webb CD; House AA; Bend JR J Pharmacol Exp Ther; 1993 Nov; 267(2):758-64. PubMed ID: 8246152 [TBL] [Abstract][Full Text] [Related]
17. Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge. Kiss L; Schütte H; Padberg W; Weissmann N; Mayer K; Gessler T; Voswinckel R; Seeger W; Grimminger F Eur Respir J; 2010 Nov; 36(5):1088-98. PubMed ID: 20378604 [TBL] [Abstract][Full Text] [Related]
18. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response. Nayeem MA; Geldenhuys WJ; Hanif A Adv Pharmacol; 2023; 97():37-131. PubMed ID: 37236764 [TBL] [Abstract][Full Text] [Related]
19. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice. Zhu Y; Blum M; Hoff U; Wesser T; Fechner M; Westphal C; Gürgen D; Catar RA; Philippe A; Wu K; Bubalo G; Rothe M; Weldon SM; Dragun D; Schunck WH PLoS One; 2016; 11(1):e0145645. PubMed ID: 26727266 [TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha. Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]